The maintenance of mature B cells hinges on signals emitted from the BAFF-R cell-surface receptor, but the nature of these signals is incompletely understood. Inhibition of canonical NF-kB transcription factor activity through ablation of the essential scaffold protein NEMO arrests B cell development at the same stage as BAFF-R deficiency. Correspondingly, activation of this pathway by constitutively active IkB Kinase2 renders B cell survival independent of BAFF-R:BAFF interactions and prevents proapoptotic PKCd nuclear translocation. In addition, canonical NF-kB activity mediates differentiation and proper localization of follicular and marginal zone B cells in the absence of BAFF-R, but not CD19. By replacing BAFF-R signals, constitutive canonical NF-kB signaling, a hallmark of various B cell lymphomas, causes accumulation of resting B cells and promotes their proliferation and survival upon activation, but does not per se induce lymphomagenesis. Therefore, canonical NF-kB activity can substitute for BAFF-R signals in B cell development and pathogenesis.
Introduction
The survival of mature B cells critically depends on the presence of two cell-surface proteins: the receptor for the cytokine B cell activation factor of the TNF family (BAFF-R, also known as BLyS receptor 3) (Ng et al., 2005) and the B cell antigen receptor (BCR) (Lam et al., 1997) . Both BAFF-R and BCR keep B cells alive through signals that either activate prosurvival mechanisms or inhibit intrinsic apoptosis-inducing programs. In the case of the BCR, it has been shown that signals transmitted through the associated Iga and Igb transmembrane proteins keep B cells alive (Kraus et al., 2004) , but the essential targets of these signals remain undefined. Binding of BAFF to BAFF-R is essential for the survival of most mature B cell subpopulations, but not for B1 cells, which reside in the peritoneal cavity (Ng et al., 2005) . Inhibition of the apoptosis-inducing properties of protein kinase Cd (PKCd) (Mecklenbrauker et al., 2004) and activation of NF-kB proteins (Gerondakis and Strasser, 2003; Siebenlist et al., 2005) have been proposed as critical downstream mediators.
Mecklenbrauker and coworkers showed that BAFFmediated B cell survival involves the control of the subcellular localization of PKCd. In the absence of BAFF, PKCd can be detected in the nucleus, where it seems to have a proapoptotic role. Loss of PKCd renders B cells independent of BAFF-R, consistent with the notion that BAFF somehow prevents nuclear localization of PKCd and thereby inhibits its proapoptotic functions (Mecklenbrauker et al., 2004) .
Transcription factors of the NF-kB family play an important role in B cell maintenance (Gerondakis and Strasser, 2003; Siebenlist et al., 2005) . Two major pathways leading to NF-kB activation have been described, termed the canonical and alternative pathways (Hayden and Ghosh, 2004) . BCR triggering leads to canonical NF-kB activity, whereas BAFF induces both pathways (Siebenlist et al., 2005) . Specific abrogation of BCRinduced NF-kB activation by ablation of Bcl-10 (Ruland et al., 2001) or Caspase recruitment domain family 11 (CARD11, Carma1, Bimp3) Jun et al., 2003) suggested that the survival signal afforded by the BCR may not depend on NF-kB. The significance of either pathway of NF-kB activation in the context of BAFF-Rmediated B cell survival is not clear. Disruption of alternative NF-kB signaling severely compromises B cell development (Kaisho et al., 2001; Senftleben et al., 2001; Yamada et al., 2000) , and we have previously shown that in vivo mature B cell maintenance and/or generation depends on IkB Kinase (IKK)-mediated, canonical NF-kB signaling (Pasparakis et al., 2002) . Combined ablation of the NF-kB transcription factors p105 (NF-kB1) and p100 (NF-kB2) blocks B cell development at the most immature stage in the spleen (Claudio et al., 2002) . However, the B cell-autonomous roles of each individual NF-kB activation pathway remain to be defined.
Five NF-kB proteins have been described in mammalian cells: RelA, c-Rel, RelB, p50, and p52 (Hayden and Ghosh, 2004) . The latter two are generated through proteolytic processing from their respective precursors p105 and p100. Rel transcription factors form various hetero-and homodimers, whose transcriptional activities are limited through binding to members of the inhibitor of kB (IkB) protein family. The IkB proteins-IkBa, IkBb, IkB3, and the precursor proteins p105 and p100-share a domain of five to seven ankyrin repeats, which enables them to associate with and prevent DNA binding of Rel dimers. Upon activation, these transcription factors control the expression of genes involved in inflammation, protection against apoptosis, and cell cycle progression (Hayden and Ghosh, 2004; Karin et al., 2002; Siebenlist et al., 2005) . The two NF-kB activation pathways employ shared and distinct components (Hayden and Ghosh, 2004) : for canonical NF-kB activation, the IKK complex, consisting of the two kinases IKK1(IKKa) and IKK2 (IKKb) and a regulatory subunit, termed NF-kB essential modulator (NEMO or IKKg), phosphorylates IkB proteins at two conserved N-terminal serine residues, leading to their polyubiquitylation and destruction by the proteasome. This pathway activates predominantly heterodimers consisting of p50, RelA, and c-Rel. The alternative pathway involves the proteolytic processing of p100 to p52, initiated by NF-kB-inducing kinase (NIK) and IKK1, independently of NEMO, and induces mostly RelB-containing complexes.
Competition for BAFF limits B cell numbers. In conditions of pathological B cell expansion, as in the case of lymphomas, this limitation somehow has been overcome. Elevated BAFF levels were found in serum derived from patients with non-Hodgkin's lymphoma (NHL), B cell chronic lymphocytic leukemia (B-CLL), and multiple myeloma (MM) (Ng et al., 2005) . Certain B lymphoma cells were shown to express BAFF and one or more of the BAFF receptors, suggesting the existence of an autocrine loop ensuring the survival of these cells (Ng et al., 2005) . In agreement with this notion, BAFF levels increase as tumors of NHL patients transform to a more aggressive phenotype (Novak et al., 2004) , and it was shown that blocking BAFF and a proliferation-inducing ligand (APRIL) results in apoptosis of NHL B cells (He et al., 2004) or B-CLL cells (Kern et al., 2004) . BAFF-treatment induced NF-kB activation and upregulation of the NF-kB targets Bcl-2, Bcl-xL, and Mcl-1 in NHL (He et al., 2004) and B-CLL (Kern et al., 2004) cells, indicating that BAFF mediates tumor cell survival through NF-kB. Therefore it appears possible that constitutive activation of the IKK complex and canonical NF-kB activity, as found in activated B cell-like diffuse large B cell lymphoma (ABC DLBCL), MALT lymphomas, and in Hodgkin and Reed-Sternberg cells (Karin et al., 2002) , serves to liberate these B cell lymphoma cells from their BAFF dependence.
To assess the role of NEMO and therefore the ability to activate the canonical NF-kB pathway throughout B cell development, we analyzed mice that lack this protein from the B cell progenitor stage on. NEMO-deficient B cells, similar to B cells lacking the BAFF-R, develop normally in the bone marrow but display a severe block in B cell development at the transitional stages in the spleen. To evaluate the significance of this finding, we then set out to determine to what extent canonical NF-kB activity can replace BAFF-R signaling in B cells. This seemed particularly interesting in the context of the constitutive activation of the IKK complex observed in many B cell tumors. Activation of the canonical NF-kB pathway through conditional expression of a constitutively active IKK2 (IKK2ca) specifically in B cells led to hyperplasia, due to prolonged B cell survival. It also completely uncoupled B cell development from all aspects of its BAFF-R dependence. In the absence of BAFF-R, IKK2ca activity mediated mature B cell survival, possibly through retaining PKCd in the cytoplasm and the full differentiation of follicular and MZ B cells. This effect is specific for BAFF-R and NF-kB signaling, since IKK2ca could not induce differentiation of CD19-deficient MZ B and B1 cells. IKK2ca-expressing B cells remained in a resting state, but canonical NF-kB activity strongly enhanced aIgM-induced proliferation.
Results
Ablation of NEMO Blocks B Cell Development at the Transitional Stages, Similar to Loss of BAFF-R Our previous analyses demonstrated that IKK2 and NEMO are required in a B cell-intrinsic fashion for the maintenance of mature B lymphocytes (Pasparakis et al., 2002) . However, the kinetics and efficiency of recombination of loxP-flanked alleles achieved by Cre expressed from the CD19 locus did not allow us to define the role of canonical NF-kB signaling in early B cell development in the bone marrow and in transitional B cells in the spleen (Pasparakis et al., 2002) . We therefore employed the Mb-1Cre strain to ablate NEMO, and thereby canonical NF-kB activity (Hayden and Ghosh, 2004) , in all B lineage cells. Early B cell development occurred normally in the absence of NEMO ( Figure 1A and data not shown), but there was a dramatic reduction in peripheral B cell numbers compared to control mice ( Figures 1A-1D ). The numbers of mature, AA4.1 2 B cells in Mb-1Cre/Nemo FL (B cell DNEMO ) were reduced to 10% compared to control mice, and there was a pronounced block in B cell development at the transitional stage 1 (T1) in the spleen ( Figure 1B ). The lack of IgD + IgM low transitional B cells reflects the T1 to T2 block as defined by CD23 expression ( Figure 1B ). In addition, marginal zone B cells could not be detected in B cell DNEMO mice by FACS ( Figure 1C ) or immunohistochemistry (Figure 1E) , and B1 cells were essentially absent from the peritoneal cavity ( Figure 1D ) and spleen (data not shown). The few residual B1 cells found in B cell DNEMO mice were CD5 2 B1b cells (data not shown). We performed Southern blot ( Figure 2A ) and immunoblot ( Figure 2B) ) mice (Sasaki et al., 2004; Shulga-Morskaya et al., 2004) , suggesting that BAFF-R-mediated activation of the canonical branch of NF-kB activation could play an essential role in B cell survival. Since the expression of p100 and RelB, both essential components of the alternative pathway of NF-kB signaling, is under NF-kB control (Beinke and Ley, 2004) , we evaluated the levels of RelB, p100, and p52 in purified NEMO-deficient and control B cells by Western blot ( Figure 2B ). These analyses revealed that RelB and p100 are produced in the absence of NEMO, albeit at lower levels than in control B cells. Significant amounts of p52 are generated in NEMO-deficient mature B cells ( Figure 2B ), indicating that BAFF-Rdependent p100 processing is still intact. Therefore, the phenotype of NEMO-deficient B cells should be mostly due to the absence of canonical NF-kB activity.
BAFF induces phosphorylation of IkBa (Hatada et al., 2003) , but it is not known which of the three BAFF receptors on B cells (BCMA, TACI, or BAFF-R) is responsible for this effect. Since the BAFF-R is solely responsible for B cell maintenance (Sasaki et al., 2004; Shulga-Morskaya et al., 2004) , BAFF-dependent survival signals should be transmitted through this receptor. BAFF treatment led to IkBa phosphorylation in control bcl-2tg, but not in bcl-2tg/BAFF-R-deficient B cells (see Figure S1A in the Supplemental Data available with this article online), demonstrating that the BAFF-R is required for BAFF-induced canonical NF-kB activity, in addition to the processing of p100 to p52 (Claudio et al., 2002) . BAFF-R-mediated IkBa phosphorylation occurred with slow kinetics, which paralleled the processing of p100 to p52 ( Figure S1A ). BAFF stimulation did not reduce IkBa steady-state protein levels, indicating that induced degradation of IkBa is balanced by resynthesis, as proposed previously (Hatada et al., 2003) . To exclude the possibility that this finding is due to the transgenic overexpression of Bcl-2, we repeated the experiment in wildtype B cells and found phosphorylation of IkBa 24 hr after BAFF treatment ( Figure S1B ). Our results show that BAFF-induced IkBa phosphorylation depends on the BAFF-R and that disruption of canonical NF-kB signaling has a similar impact on B cell development as BAFF-R deficiency.
Expression of Constitutively Active IKK2 in B Cells
Selectively Induces Canonical NF-kB Activation In order to evaluate the extent to which constitutive canonical NF-kB activation can replace BAFF-R signals, we decided to activate this pathway in a conditional fashion. We knocked a cDNA encoding IKK2 containing two serine to glutamate substitutions in the activation loop of the kinase domain, preceded by a loxP-flanked STOP cassette, into the ubiquitously expressed ROSA26 locus ( Figure 3A and Figure S2 ). IKK2 containing these serine to glutamate mutations (IKK2ca) is constitutively active (Mercurio et al., 1997) . We termed the mutant allele R26Stop FL ikk2ca and crossed mice carrying this allele to the CD19cre mouse strain (Rickert et al., 1995) ( Figure 3B ), and expression of the Flag-tagged IKK2ca can be detected by immunoblot ( Figure 3C ).
These B cells contain very low levels of IkBa and IkBb ( Figure 3D ), indicating that IKK2ca is indeed constitutively active. IkB3 levels, on the other hand, are elevated in IKK2ca + compared to control B cells ( Figure 3D ). Since IkB3 is a transcriptional target of NF-kB (Tian et al., 2005) , it seems that IKK2ca activity induces more synthesis than degradation of IkB3. IKK2ca + resting B cells have higher nuclear levels of p50, RelA, and c-Rel than control cells, but not of p52 and RelB ( Figure 3E ). IKK2ca expression also increases DNA binding of p50, RelA, and, to a lesser extent, c-Rel, containing nuclear complexes in B cells that were cultured in medium overnight ( Figure 3F ). We were not able to detect a clear supershift with antibodies directed against RelA ( Figure 3F ), but two different anti-RelA antibodies also induced the disappearance of the more slowly migrating NF-kB complexes ( Figure S3B ), indicating that they are comprised of mostly p50 and RelA. In both control and IKK2ca + B cells, p52-containing complexes can be detected in ex vivo isolated B cells ( Figure S3A) , showing that BAFF activates p100 processing in the presence of IKK2ca in vivo. When cultured in the absence of BAFF, NF-kB dimers containing p52 largely disappear ( Figure 3F and dat not shown). The consequence of this continuous IKK2 activity is increased expression of NF-kB targets such as p100, RelB, and Bcl-xL ( Figure 3D ). We therefore confirm that in B cells constitutive activation of IKK2 mediates canonical, but not alternative, NF-kB activity.
Constitutive Canonical NF-kB Activity Causes B Cell Hyperplasia, Especially of Marginal Zone B Cells The CD19cre allele does not facilitate efficient expression of IKK2ca during bone marrow B cell development in B cell Ikk2ca mice, and the constitutive activation of IKK2 present in B lineage cells has no obvious effect on early B cell development ( Figures S4A and S4B ). Virtually all B cells express IKK2ca from the transitional stages onward in the spleens of B cell Ikk2ca mice ( Figure S4C ), resulting in an increase in peripheral B cell numbers ( Figures 4A and 4B ), which is due to an overall increase in mature AA4.1 2 B cells (130.2 6 32.7 3 10 6 in B cell Ikk2ca versus 56.4 6 9.3 3 10 6 in control mice; n = 7-8) ( Figure 4A ). IKK2ca + B cells contain a significantly expanded population of marginal zone (MZ) B cells, as shown by FACS (22.3 6 6.9 3 10 6 in B cell Ikk2ca versus 4 6 1.5 3 10 6 in control mice; n = 7-8) ( Figure 4A ) and immunohistochemistry ( Figure 4B ), underscoring the importance of canonical NF-kB signaling in the generation of this subset. IKK2ca + B cells show elevated levels of CD23, consistent with the presence of two kB sites in the promoter of the CD23 gene (Tinnell et al., 1998) . However, the presence of CD23 low transitional T1 (data not shown) and MZ (Fig. 4A) Figure 4C ) indicates that IKK2ca + B cells have on average a longer life span than wild-type B cells. Since we did not differentiate between individual B cell subsets, it is possible that phenomena such as the preferential recruitment of IKK2ca-expressing B cells into the MZ B cell compartment contribute to the reduced B cell turnover. However, given the absence of increased B cell generation and IKK2ca-induced proliferation, it is clear from the data that the doubling of B cell numbers, effected by IKK2ca, cannot be explained by changes in the size of individual B cell subsets. Therefore, IKK2ca causes B cell hyperplasia not through increasing their generation or inducing proliferation but by enhancing B cell life span. Figure 4D ). In order to verify this finding in vivo, we generated B cell high MZ B cells ( Figure 5A ). Immunohistochemistry revealed that spleens from B cell
Ikk2ca
-BAFF-R-deficient mice contain a well-organized lymphoid microarchitecture, displaying clear B and T cell areas and normal follicles with a distinct marginal zone area ( Figure 5B ).
Canonical NF-kB Activity Prevents Proapoptotic Nuclear Entry of PKCd in Response to BAFF Deprivation B cell apoptosis resulting from withdrawal of BAFF has been linked to nuclear localization of PKCd. We show here that the nuclear accumulation of PKCd is downstream of IKK2 activation, since PKCd does not translocate to the nucleus of IKK2ca + B cells cultured in the absence of BAFF or lacking the BAFF-R ( Figure 5C ). Expression of IKK2ca did not restore processing of p100 to p52 in BAFF-R-deficient B cells ( Figure 5C ), demonstrating that in the presence of canonical NF-kB activity p100 processing is not required for B cell development. Enforced expression of Bcl2 also inhibits PKCd nuclear translocation ( Figure 5D ) and permits the development of large numbers of BAFF-R-deficient AA4.1 2 B cells (Sasaki et al., 2004) . We therefore suggest that NF-kB signaling controls the proapoptotic functions of PKCd through the induction of NF-kB-dependent Bcl-2 family proteins.
IKK2 Activity Cannot Replace CD19-Dependent Differentiation Signals
Loss of CD19 results in various B cell deficiencies, including reduced numbers of follicular B cells and absence of MZ B and B1 cells (Engel et al., 1995; Rickert et al., 1995) . Ablation of phosphatase and tensin homolog (PTEN), a functional antagonist of PI3K, led to MZ and B1 cell development in CD19 2/2 mice , demonstrating that phosphoinositide 3-kinase (PI3K) activity can induce differentiation of these B cell subsets in the absence of CD19. Activation of PI3K also leads to NF-kB activation (Donahue and Fruman, 2004) . Therefore, we evaluated to what extent expression of IKK2ca can compensate for the lack of CD19. We found that IKK2ca increased the numbers of mature AA4.1 2 B cells in B cell Ikk2ca -CD19 2/2 mice ( Figure 6A ), but did not induce MZ B or B1 cell development ( Figures 6A-6C ). This result shows that IKK2ca-mediated activation of canonical NF-kB is not sufficient to replace differentiation signals downstream of CD19-dependent PI3 kinase activation.
IKK2ca Expression Keeps B Cells in a Resting State, but Promotes Proliferation upon Activation
We performed cell cycle analyses on purified IKK2ca + and control B cells to directly test the role of constant canonical NF-kB activation on B cell division. Nearly all ex vivo isolated IKK2ca + B cells were in a resting state, similar to control B cells ( Figure 7A ). However, 1 or 2 days after BCR crosslinking, IKK2ca + B cells contained more cells in S phase and less apoptotic cells than control B cells, indicating that canonical NF-kB activity enhances aIgM-induced proliferation in addition to protecting against apoptosis ( Figure 7A ). Similarly, CMTMR-labeled IKK2ca + B cells started dividing earlier, underwent more cell divisions, and stayed alive longer than control B cells in response to stimulation with aIgM ( Figure 7B ). As a result, 4 days after start of cultures with 2 3 10 6 B cells in the presence of aIgM, 3 3 10 6 live IKK2ca + B cells could be recovered, in comparison to 0.12 3 10 6 live control B cells. Biochemical analysis of NF-kB-dependent proteins involved in cell cycle regulation (Karin et al., 2002; Rosenwald and Staudt, 2003) revealed no significant differences between resting IKK2ca + and control B cells ( Figure 7C ). Proviral integration site (Pim)-1 and IRF-4 were included in this analysis because they belong to a group of NF-kBdependent genes that are highly expressed in ABC DLBCL and which also include Bcl-2, FLICE-like inhibitory protein (FLIP), and cyclin D2. After stimulation with aIgM, IKK2ca + B cells contained higher levels of cyclin D3, cyclin E, Cdk4, Cdk6, and especially of pim-1 ( Figure 7C ). These findings demonstrate that IKK2 activity alone does not induce cell cycle entry but dramatically promotes the proliferation of activated B cells.
Discussion
Canonical NF-kB activity is essential for B cell maintenance. Signals from two receptors, BCR and BAFF-R, are essential for the survival of mature, resting B cells, and both activate the canonical NF-kB pathway. Loss of Bcl-10 essentially prevents the generation of B1 cells but affects the numbers of other mature peripheral B cells (B2) only modestly (Xue et al., 2003) . Therefore, it appears unlikely that NF-kB/Rel proteins play a major role in BCRmediated maintenance signals in B2 cells. Since B cellspecific ablation of NEMO, and therefore canonical NFkB activity, completely interferes with the generation of B1 cells, we present here further evidence that this particular B cell subset depends on BCR-mediated activation of the canonical NF-kB pathway. In B2 cells, on the other hand, it seems possible that the BAFF-R signals B cell survival via NF-kB (Gerondakis and Strasser, 2003; Siebenlist et al., 2005) . However, BAFF-R ligation stimulates both the canonical and the alternative pathway of NF-kB activation, and it is thought that it preferentially stimulates the latter (Morrison et al., 2005) . Alternative NF-kB activity contributes to BAFF-R-mediated survival, but the BAFF-R must provide additional survival signals, since loss of the ability to induce alternative signaling leads to a milder reduction in B cell numbers than lack of BAFF or BAFF-R (Siebenlist et al., 2005) . The increase in phosphorylated IkBa, mediated by BAFF, which we show to depend on the BAFF-R, follows a slow kinetic, consistent with the notion of a continuous, low-level maintenance signal. The fact that BAFF treatment induces IkBa phosphorylation and p100 processing with a similar kinetics supports the notion that a common upstream protein, most likely NIK (Ramakrishnan et al., 2004) , activates both canonical and alternative NF-kB in response to BAFF. However, it is also possible that BAFF activates canonical NF-kB through indirect mechanisms. Our finding that ablation of NEMO produces a block in B cell development similar to loss of the BAFF-R supports the idea that canonical NF-kB signals play a role in BAFF-mediated B cell survival and/or differentiation. Loss of NEMO, although reflecting impaired signaling to canonical NF-kB activation in response to triggering of the BCR and perhaps other not yet identified receptors in addition to BAFF-R, produces a slightly milder B cell phenotype than lack of BAFF-R (Sasaki et al., 2004; Shulga-Morskaya et al., 2004) . Therefore, other BAFF-R-induced signaling pathways, such as the alternative NF-kB pathway and the regulation of Bim by ERK (Craxton et al., 2005) , could contribute to B cell maintenance. We did not detect any obvious differences in bone marrow development between NEMO-deficient and control B cells, in agreement with the in vitro data of Kim et al. (2003) and are currently investigating whether specific processes linked to NF-kB transcription factors, such as receptor editing (Verkoczy et al., 2005) , depend on NEMO.
Overexpression of Bcl2 (Rahman and Manser, 2004; Sasaki et al., 2004; Tardivel et al., 2004) or Bcl-xL (Amanna et al., 2003) leads to the development of large numbers of BAFF-R-deficient B cells. However, only follicular B cells, with a surface phenotype reminiscent of immature cells and lacking proper follicular organization, are generated in these mice. In contrast, IKK2 activity, and therefore canonical NF-kB signaling, can fully compensate for BAFF-R in the generation and maintenance of mature B cell subsets, namely survival and differentiation of properly organized mature follicular and MZ B cells, as well as the expression of CD21 and CD23. This finding excludes the possibility that BAFF-expressing stromal cells (Gorelik et al., 2003) directly act as an organizing principle ensuring the proper follicular location of B cells.
Our data indicate that BAFF-R-mediated cytoplasmic retention of PKCd, which prevents its nuclear proapoptotic activities, is downstream of canonical NF-kB activity and Bcl-2 expression. Therefore, nuclear exclusion of PKCd through NF-kB-induced expression of antiapoptotic members of the Bcl-2 family could contribute to BAFF-R-dependent B cell maintenance. The NF-kBdependent, BAFF-R-induced mechanisms mediating differentiation of follicular and MZ B cells are currently under investigation.
The fact that canonical NF-kB signaling can increase the numbers of follicular B cells generated in the absence of CD19 is consistent with the increase in follicular B cell numbers in cd19 2/2 mice through enforced expression of Bcl-2 (Otero et al., 2003) and the rescue of B cell deficiency in p85a 2/2 mice, which lack the major regulatory subunit of PI3K, by transgenic expression of Bcl-xL, another NF-kB target . On the other hand, IKK2ca expression does not lead to the generation of CD19-deficient MZ B or B1 cells, demonstrating that the CD19-induced PI3K activity does not signal MZ B and B1 cell differentiation via canonical NF-kB activity. This conclusion is potentially in conflict with data from Otero et al., who reported that transgenic expression of Bcl-2 can rescue the generation of CD19-deficient MZ B cells, but not B1 cells (Otero et al., 2003) .
Here, we provide evidence for an important role of canonical NF-kB signaling in BAFF-R-mediated B cell survival and differentiation, through in vivo ablation and constitutive induction of this particular pathway. Although constitutive canonical NF-kB activation can replace BAFF-R signals and inhibition of this pathway mimics loss of BAFF-R to a large extent, we cannot precisely define the respective impact of the canonical and alternative NF-kB pathway on BAFF-R signaling during normal B cell physiology. Specific mutations in the BAFF-R or downstream mediators disabling selectively either of the two pathways and/or a comparison of the B cell-specific inhibition of each of the two branches of NF-kB activation will be required to fully address this question. To this end we are currently generating mouse models to ablate and constitutively activate alternative NF-kB signaling.
Our knockin system to conditionally activate canonical NF-kB through expression of constitutively active IKK2 is uniquely suited to explore the role of this signaling pathway in the pathogenesis of B cell malignancies, where canonical NF-kB signaling is constitutively active. An important result of the present experiments is the demonstration that despite its involvement in the control of both cell survival and proliferation, constitutive canonical NF-kB signaling leads to B cell hyperplasia and ImmunityBAFF independence, without by itself inducing B cell proliferation. This is underscored by our finding that increased canonical NF-kB activity, mediated by expression of IKK2ca from two alleles, while further elevating B cell numbers, still maintains the resting state of the cells (data not shown). However, once cell division is initiated by some mitogenic stimulus, IKK2ca + B cells divide much more rapidly than control B cells.
Therefore, we propose that constitutive activation of the classical pathway of NF-kB, be it through chronic infections or chromosomal translocations as in MALT lymphomas or genetic mutations or viral infections as in certain cases of Hodgkin's lymphoma (Karin et al., 2002) , while not being oncogenic by itself, predisposes B cells to transformation in at least two ways: it releases the B cells from their dependence of extracellular survival signals, such as BAFF, and when an additional oncogenic event induces the cells to divide, it protects them against activation-induced apoptosis and strongly enhances proliferation.
With respect to normal B cell physiology, our results demonstrate that BAFF-R ligation induces canonical NF-kB activity and that expression of IKK2ca renders mature resting B cells fully independent of BAFF. NF-kB can mediate BAFF-dependent B cell survival through upregulation of antiapoptotic proteins of the Bcl-2 family and suppression of PKCd nuclear translocation and has additional roles in BAFF-dependent differentiation of marginal zone B cells. Together with the phenotypic similarities between BAFF-R-and NEMO-deficient B cells, our data provide strong evidence for a role of canonical NF-kB signals in BAFF-R-mediated B cell survival and differentiation.
Experimental Procedures
Genetically Modified Mice To generate tissue-specific IKK2ca-transgenic mice, we cloned a loxP-flanked neo r -stop cassette into a modified version of pROSA26-1 (Zambrowicz et al., 1997) . We then added a cDNA encoding a flag-tagged constitutively active form of murine IKK2 (IKK2ca), a frt-flanked IRES-eGFP cassette, and a bovine polyadenylation sequence (R26Stop FL Ikk2ca; Figure S2 ). Bruce-4 ES cells were transfected, cultured, and selected as previously described (Schmidt-Supprian et al., 2000) . Mice carrying conditional Nemo alleles were described previously (Schmidt-Supprian et al., 2000) . Mb-1Cre mice were generated through knockin of a Cre-encoding cDNA into the mb-1 locus and will be described elsewhere (E.H., unpublished data). Except for the Mb-1Cre mice, which were BALB/c:C57BL/6 mixed, all mice were of a pure C57BL/6 genetic background and were bred and maintained in specific pathogenfree conditions; all mouse protocols were approved by the Harvard University Institutional Animal Care and Use Committee and by the CBR Institute for Biomedical Research. 
Flow Cytometry and Cell Purifications
Single-cell suspensions prepared from various lymphoid organs were stained with the following monoclonal antibodies conjugated to phycoerythrin (PE), Peridin-Chlorophyll (PerCP), allophycocyanin (APC), or biotin: anti-CD19 (ID3), anti-CD21 (7G6), anti-CD23 (B3B4), anti-CD1d (1B1) (all from BD Pharmingen), and anti-AA4.1 (eBioscience). For in vitro proliferation studies, B cells were labeled with 10 mM Celltracker Orange (Invitrogen) for 15 min at 37ºC. All samples were acquired on a FACSCalibur (BD Pharmingen), and results were analyzed with Flow-Jo and CellQuest software. B cells were purified by MACS (Miltenyi) and by cell sorting using a FACS DiVA (Becton Dickinson). MACS-purified populations were >85% pure and FACS purifications yielded >95% purity.
Immunohistochemistry
For staining of B cells and macrophages, frozen 6 mm sections were thawed, air-dried, fixed in acetone, and stained for 1 hr at RT in a humidified chamber with biotinylated rat anti-CD19 (BD Pharmingen) or rat anti-B220 and rat anti-MOMA-1 (CEDARLANE) followed by HRP-conjugated goat anti-rat IgG and alkaline phosphataseconjugated streptavidin. For staining of B and T cells, sections were stained for 1 hr at RT in a humidified chamber with biotinylated anti-CD19 and armenian hamster anti-CD33 (eBioscience).
BrdU Pulse-Chase Experiments
Mice were fed with drinking water containing 0.8 mg/ml BrdU (Sigma) for 14 days. At different times during and after the BrdU pulse, splenocytes were purified and stained using the APC BrdU Flow kit (BD bioscience).
Cell Cycle Analysis
Purified B cells (2 3 10 7 ) were cultured in 5 ml medium and stimulated with 10 mg/ml of aIgM. At each time point, 2 3 10 6 cells were harvested and washed with PBS. Cells were resuspended in 500 ml PBS and fixed by adding 1 ml of ice-cold 95% ethanol. After overnight incubation on ice, the cells were washed with PBS and resuspended in 200 ml of 0.5 mg/ml RNaseA and incubated at 37ºC for 20 min. Subsequently, 200 ml of 40 mg/ml propidium iodide (Sigma) was added, and the B cells were incubated for 30 min at RT. DNA content was then quantified by FACS.
Immunoblot Analysis and Electrophoretic Mobility Shift Assay
To prepare whole-cell lysates, B cells were lysed for 10 min on ice by RIPA buffer + 1% aprotinin and 2 mM PMSF, followed by 10 min centrifugation. For preparation of cytoplasmic fractions, cells were washed once with PBS and resuspended in 100 ml buffer A (10 mM HEPES [pH7.8], 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, 5 mg/ml aprotinin, 2 mM pepstatin, 10 mg/ml leupeptin, 1 mM PMSF, 5 mM NaF, 1 mM Na 3 VO 4 , and 0.5% Triton X-100), followed by 10 min centrifugation. For nuclear extracts, the nuclei were then resuspended in buffer C (50 mM HEPES [pH 7.8], 420 mM KCl, 0.1 mM EDTA, 5 mM MgCl 2 , 10% glycerol, 1 mM DTT, 5 mg/ml aprotinin, 2 mM pepstatin, 10 mg/ml leupeptin, 1 mM PMSF, 5 mM NaF, 1 mM Na 3 VO 4 ) for EMSA or resuspended in RIPA buffer + 1 mM DTT, 5 mg/ml aprotinin, 2 mM pepstatin, 10 mg/ml leupeptin, 1 mM PMSF, 5 mM NaF, 1 mM Na 3 VO 4 , and then sonicated three times for 5 min for immunoblot for PKCd. PVDF membranes were blotted with the indicated antibodies. EMSA was performed essentially as described (Schmidt-Supprian et al., 2000) . For supershift assays, nuclear extracts or whole-cell lysates were preincubated for 30 min at RT with the indicated antibodies.
Cell Survival Assay Splenic B cells were purified by depletion of CD43 + cells by MACS (Miltenyi). B cells (4 3 10 6 ) were cultured in 1 ml medium with or without 500 ng/ml human BAFF (Pelletier et al., 2003) . At each time point, live cells were counted.
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